logo

For the Inventor, By the Inventor

Vallentuna, Sweden

Matthias Corbascio

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Swedish Stromabio Ab, Isletone Ab. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Corbascio. Retrieved from https://idiyas.com/inventor/matthias-corbascio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 2 
 
Swedish Stromabio Ab
 patents
silverMedal1 out of 1 
 
Isletone Ab
 patent

Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 11607429 - Derivation and self-renewal of ISI1+ cells and uses thereof (2023-03-21),
2. 10751370 - Immunomodulatory compositions (2020-08-25),
3. 10226487 - Derivation and self-renewal of lsl1+ cells and uses thereof (2019-03-12),

Title: Matthias Corbascio - Innovator Revolutionizing Medical Science

Introduction:

Matthias Corbascio, a visionary inventor based in Vallentuna, SE, is making waves in the world of medical science with his groundbreaking innovations. With a passion for pushing boundaries and a keen eye for technological advancements, Corbascio is at the forefront of revolutionizing the healthcare industry.

Latest Patents:

Matthias Corbascio holds a total of 3 patents, with his latest inventions focused on advancing regenerative medicine and immunotherapy. One of his patents titled "Derivation and self-renewal of ISI1+ cells and uses thereof" explores methods for deriving multipotent Isl1+ cells and their differentiation into cardiac cells for medical applications. Another patent revolves around "Immunomodulatory compositions" comprising mesenchymal cells and additional agents for immune system modulation in various diseases and conditions.

Career Highlights:

Corbascio has made significant contributions to the field of biotechnology through his work at renowned companies such as Swedish Stromabio AB and Isletone AB. His expertise in cellular biology and regenerative medicine has led to the development of novel therapies with the potential to transform patient care.

Collaborations:

Throughout his career, Matthias Corbascio has collaborated with esteemed professionals in the industry, including coworkers like Oscar Simonson and Christer Sylvén. These collaborations have not only enhanced the quality of his inventions but have also fostered a collaborative spirit within the scientific community.

Conclusion:

In conclusion, Matthias Corbascio stands as a true luminary in the realm of medical innovation, with a remarkable portfolio of patents that showcase his commitment to advancing healthcare technologies. His pioneering spirit and dedication to excellence continue to inspire innovation and drive progress in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…